Unknown

Dataset Information

0

Gut Microbial-Related Choline Metabolite Trimethylamine-N-Oxide Is Associated With Progression of Carotid Artery Atherosclerosis in HIV Infection.

ABSTRACT: We examined associations of 5 plasma choline metabolites with carotid plaque among 520 HIV-infected and 217 HIV-uninfected participants (112 incident plaque cases) over 7 years. After multivariable adjustment, higher gut microbiota-related metabolite trimethylamine-N-oxide (TMAO) was associated with an increased risk of carotid plaque in HIV-infected participants (risk ratio = 1.25 per standard deviation increment; 95% confidence interval, 1.05-1.50; P = .01). TMAO was positively correlated with biomarkers of monocyte activation and inflammation (sCD14, sCD163). Further adjustment for these biomarkers attenuated the association between TMAO and carotid plaque (P = .08). Among HIV-infected individuals, plasma TMAO was associated with carotid atherosclerosis progression, partially through immune activation and inflammation.

SUBMITTER: Shan Z 

PROVIDER: S-EPMC6151074 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Gut Microbial-Related Choline Metabolite Trimethylamine-N-Oxide Is Associated With Progression of Carotid Artery Atherosclerosis in HIV Infection.

Shan Zhilei Z   Clish Clary B CB   Hua Simin S   Scott Justin M JM   Hanna David B DB   Burk Robert D RD   Haberlen Sabina A SA   Shah Sanjiv J SJ   Margolick Joseph B JB   Sears Cynthia L CL   Post Wendy S WS   Landay Alan L AL   Lazar Jason M JM   Hodis Howard N HN   Anastos Kathryn K   Kaplan Robert C RC   Qi Qibin Q  

The Journal of infectious diseases 20180901 9

We examined associations of 5 plasma choline metabolites with carotid plaque among 520 HIV-infected and 217 HIV-uninfected participants (112 incident plaque cases) over 7 years. After multivariable adjustment, higher gut microbiota-related metabolite trimethylamine-N-oxide (TMAO) was associated with an increased risk of carotid plaque in HIV-infected participants (risk ratio = 1.25 per standard deviation increment; 95% confidence interval, 1.05-1.50; P = .01). TMAO was positively correlated with  ...[more]

Similar Datasets

Transcriptomics Gut microbial metabolite trimethylamine N-oxide aggravates pulmonary hypertension
2022-06-07 | GSE190203 | GEO
Unknown Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy.
| S-EPMC8650703 | biostudies-literature
Unknown Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.
| S-EPMC8052457 | biostudies-literature
Unknown Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure.
| S-EPMC4943035 | biostudies-literature
Unknown Rapid Detection of Gut Microbial Metabolite Trimethylamine N-Oxide for Chronic Kidney Disease Prevention.
| S-EPMC8469701 | biostudies-literature
Unknown Long-Term Changes in Gut Microbial Metabolite Trimethylamine N-Oxide and Coronary Heart Disease Risk.
| S-EPMC8140616 | biostudies-literature
Unknown Choline metabolite, trimethylamine N-oxide (TMAO), is associated with inflammation in psoriatic arthritis.
| S-EPMC6529247 | biostudies-literature
Unknown Facile Fluorescence Monitoring of Gut Microbial Metabolite Trimethylamine N-oxide via Molecular Recognition of Guanidinium-Modified Calixarene.
| S-EPMC6643440 | biostudies-literature
Genomics Gut microbial metabolite trimethylamine N-oxide aggravates pulmonary hypertension
| PRJNA786337 | ENA
Unknown The Gut Microbial Metabolite Trimethylamine N-Oxide and Hypertension Risk: A Systematic Review and Dose-Response Meta-analysis.
| S-EPMC7442397 | biostudies-literature